Arcadia Biosciences
RKDA
Arcadia Biosciences (RKDA) - P/B ratio
P/B ratio as of April 2024 : 0.2192
According to Arcadia Biosciences's latest financial reports the company has a price-to-book ratio of 0.2192.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Arcadia Biosciences - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.2736 | -14.38% |
| 2022-12-31 | 0.3195 | -56.79% |
| 2021-12-31 | 0.7396 | -37.95% |
| 2020-12-31 | 1.19 | -79.06% |
| 2019-12-31 | 5.69 | 381.79% |
| 2018-12-31 | 1.18 | -19.43% |
| 2017-12-31 | 1.47 | -20.48% |
| 2016-12-31 | 1.84 | -44.79% |
| 2015-12-31 | 3.34 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Codexis
CDXS | 2.48 | 1,029.20% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | -10.1 | -4,693.43% | 🇺🇸 USA |
 American Vanguard AVD | 0.9066 | 313.54% | 🇺🇸 USA |